Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-08 Purchase |
2021-08-20 1:38 pm |
Brooklyn ImmunoTherapeutics Inc. | BTX | DENNY GEORGE P III 10% Owner |
3 | $13.48 | $40 | 38,682 (Indirect Direct) |
View |
| 2021-07-06 Sale |
2021-08-20 1:38 pm |
Brooklyn ImmunoTherapeutics Inc. | BTX | DENNY GEORGE P III 10% Owner |
75,000 | $16.06 | $1,204,688 | 38,682 (Indirect Direct) |
View |
| 2021-06-16 Sale |
2021-06-21 6:00 pm |
Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director 10% Owner |
400,000 | $15.74 | $6,296,568 | 5,894,101 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-01 Option Award |
2022-08-03 8:01 pm |
N/A 2032-08-01 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Wexler William A. Director |
317,900 | $0 | 317,900 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-03 8:01 pm |
N/A 2032-08-01 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Singer Nicholas Jason Director |
311,900 | $0 | 311,900 (Direct) |
View |
| 2022-06-28 Tax Withholding |
2022-06-29 8:01 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | DAmour Kevin Chief Scientific Officer |
6,077 | $0.5534 | 64,213 (Direct) |
View |
| 2022-06-28 Exercise |
2022-06-29 8:01 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | DAmour Kevin Chief Scientific Officer |
17,573 | $0 | 64,213 (Direct) |
View |
| 2022-06-21 Tax Withholding |
2022-06-23 8:31 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | Gurrola Sandra M Vice President of Finance |
3,586 | $0.4765 | 39,617 (Direct) |
View |
| 2022-06-21 Exercise |
2022-06-23 8:31 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | Gurrola Sandra M Vice President of Finance |
8,750 | $0 | 39,617 (Direct) |
View |
Ownership |
2022-06-07 9:08 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | Singer Nicholas Jason Director |
0 | $0 | 2,095,000 (Indirect) |
View |
| 2022-06-03 Option Award |
2022-06-06 5:01 pm |
N/A 2032-06-03 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Jackson Andrew C. Chief Financial Officer |
664,800 | $0 | 664,800 (Direct) |
View |
Ownership |
2022-06-01 5:00 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | Angel Matthew Interim President and CEO |
0 | $0 | 3,489,666 (Direct) |
View |
| 2022-03-11 Option Award(A) |
2022-03-17 9:00 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | DAmour Kevin Chief Scientific Officer |
138,400 | $0 | 138,400 (Direct) |
View |
| 2022-03-11 Option Award(A) |
2022-03-17 9:00 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Gurrola Sandra M Vice President of Finance |
114,500 | $0 | 114,500 (Direct) |
View |
| 2022-03-11 Option Award(A) |
2022-03-17 9:00 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Federoff Howard J. CEO & President |
413,700 | $0 | 413,700 (Direct) |
View |
| 2022-03-11 Option Award(A) |
2022-03-17 9:00 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Sial Jay Chief Administration Officer |
117,200 | $0 | 117,200 (Direct) |
View |
| 2022-03-11 Option Award(A) |
2022-03-17 9:00 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Sidhu Roger Chief Medical Officer |
142,100 | $0 | 142,100 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-15 9:34 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | DAmour Kevin Chief Scientific Officer |
138,400 | $0 | 138,400 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-15 9:34 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Gurrola Sandra M Vice President of Finance |
114,500 | $0 | 114,500 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-15 9:34 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Federoff Howard J. CEO & President |
413,700 | $0 | 413,700 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-15 9:34 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Sial Jay Chief Administration Officer |
117,200 | $0 | 117,200 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-15 9:34 pm |
N/A 2032-03-11 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Sidhu Roger Chief Medical Officer |
142,100 | $0 | 142,100 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 9:46 pm |
N/A 2032-01-14 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Redman Heather B Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 9:46 pm |
N/A 2032-01-14 |
Brooklyn ImmunoTherapeutics Inc. | BTX | ENRIGHT ERIN S. Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 9:00 pm |
N/A 2031-12-07 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Greenwood Luba Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 9:00 pm |
N/A 2031-12-07 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director |
67,000 | $0 | 5,961,285 (Direct) |
View |
| 2021-06-01 Other |
2021-12-10 9:00 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director |
92 | $0 | 5,961,285 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 9:00 pm |
N/A 2031-12-07 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Mohr Erich Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 9:00 pm |
N/A 2031-12-07 |
Brooklyn ImmunoTherapeutics Inc. | BTX | LANGER DENNIS Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2021-09-20 Option Award |
2021-09-22 4:57 pm |
N/A 2031-09-20 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Sidhu Roger See Remarks |
241,950 | $0 | 241,950 (Direct) |
View |
| 2021-07-15 Option Award |
2021-07-19 9:30 pm |
N/A 2031-07-15 |
Brooklyn ImmunoTherapeutics Inc. | BTX | Sial Jay See Remarks |
106,700 | $0 | 106,700 (Direct) |
View |
| 2021-06-28 Option Award |
2021-06-30 9:34 pm |
N/A 2031-06-28 |
Brooklyn ImmunoTherapeutics Inc. | BTX | DAmour Kevin See Remarks |
210,870 | $0 | 210,870 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-22 6:01 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | Gurrola Sandra M Vice President of Finance |
35,000 | $0 | 35,000 (Direct) |
View |
Ownership |
2021-06-22 6:00 pm |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | Gurrola Sandra M Vice President of Finance |
0 | $0 | 8,203 (Direct) |
View |
Ownership |
2021-05-19 10:41 am |
N/A N/A |
Brooklyn ImmunoTherapeutics Inc. | BTX | HALPERN JOHN D Halpern Katherine H. 10% Owner |
0 | $0 | 4,780,307 (Direct) |
View |